A new trading day began on Tuesday, with Abeona Therapeutics Inc (NASDAQ: ABEO) stock price down -4.11% from the previous day of trading, before settling in for the closing price of $4.51. ABEO’s price has ranged from $3.05 to $8.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -15.07%. Meanwhile, its annual earnings per share averaged 20.86%. With a float of $42.89 million, this company’s outstanding shares have now reached $45.64 million.
Considering the fact that the conglomerate employs 136 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Abeona Therapeutics Inc (ABEO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Abeona Therapeutics Inc is 11.64%, while institutional ownership is 64.23%. The most recent insider transaction that took place on Mar 31 ’25, was worth 119,500. In this transaction Chief Executive Officer of this company sold 25,000 shares at a rate of $4.78, taking the stock ownership to the 1,355,322 shares. Before that another transaction happened on Mar 31 ’25, when Company’s Officer proposed sale 25,000 for $4.78, making the entire transaction worth $119,560.
Abeona Therapeutics Inc (ABEO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.86% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Here are Abeona Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -0.10 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Compared to the last year’s volume of 0.41 million, its volume of 0.97 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 16.38%. Additionally, its Average True Range was 0.34.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 2.38%, which indicates a significant decrease from 5.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.45% in the past 14 days, which was higher than the 46.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.31, while its 200-day Moving Average is $5.54. Nevertheless, the first resistance level for the watch stands at $4.69 in the near term. At $5.05, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.27. If the price goes on to break the first support level at $4.11, it is likely to go to the next support level at $3.89. Should the price break the second support level, the third support level stands at $3.53.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
With a market capitalization of 209.67 million, the company has a total of 48,534K Shares Outstanding. Currently, annual sales are 0 K while annual income is -63,730 K. The company’s previous quarter sales were 0 K while its latest quarter income was -9,290 K.
